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ABSTRACT
PURPOSE: To investigate the anti-inflammatory effects of simvastatin in rats undergoing one-lung ventilation (OLV) followed by lung 
re-expansion.
METHODS: Male Wistar rats (n=30) were submitted to 1-h OLV followed by 1-h lung re-expansion. Treated group received 
simvastatin (40 mg/kg for 21 days) previous to OLV protocol. Control group received no treatment or surgical/ventilation interventions. 
Measurements of pulmonary myeloperoxidase (MPO) activity, pulmonary protein extravasation, and serum levels of cytokines and 
C-reactive protein (CRP) were performed. 
RESULTS: OLV significantly increased the MPO activity in the collapsed and continuously ventilated lungs (31% and 52% increase, 
respectively) compared with control (p<0.05). Treatment with simvastatin significantly reduced the MPO activity in the continuously 
ventilated lung but had no effect on lung edema after OLV. The serum IL-6 and CRP levels were markedly higher in OLV group, but 
simvastatin treatment failed to affect the production of these inflammatory markers. Serum levels of IL-1β, TNF-α and IL-10 remained 
below the detection limit in all groups. 
CONCLUSIONS: In an experimental one-lung ventilation model pre-operative treatment with simvastatin reduces remote neutrophil 
infiltration in the continuously ventilated lung. Our findings suggest that simvastatin may be of therapeutic value in OLV-induced 
pulmonary inflammation deserving clinical investigations.
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Introduction 
The one-lung ventilation (OLV), a ventilation strategy 
used during thoracic surgery, consists in an intentional and 
temporary collapse of a lung1, while the other one remains 
normally ventilated. This ventilator strategy initiates a series 
of pathophysiologic events that can be attributed to two major 
factors, namely hypoxia and re-oxygenation. The cellular damage 
that follows the oxygen deprivation is exacerbated during the re-
oxygenation by the generation of free radicals2. OLV in animals 
has been accepted as an ideal model to produce lung injury 
associated with organ failure and high mortality levels3. The 
control of the pulmonary inflammation resulting from thoracic 
surgical manipulations has been a great challenge. Although some 
pharmacological treatments aiming suppress the acute lung injury 
or acute respiratory distress syndrome has been used, many specific 
therapies have not proved beneficial, such as mortality reduction4.
Statins are competitive inhibitors of 3-hydroxy-3-
methylglutaryl coenzyme A reductase resulting in a reduced 
cholesterol biosynthesis5. Besides, statins exert pleiotropic effects 
through reductions of pro-inflammatory cellular signaling5, 
oxidative stress 6 and leukocyte interaction with endothelial cells7. 
These anti-inflammatory effects of statins have been reported 
in ischemia and reperfusion6 and extracorporeal membrane 
oxygenation in rat models8, as well as in lung transplanted patients9. 
In the present study, we have investigated the beneficial 
effects of simvastatin in rats undergoing OLV followed by lung re-
expansion10, evaluating the pulmonary and systemic inflammatory 
processes, as well as hemodynamic and gasometric parameters. 
The beneficial of simvastatin in OLV-induced lung injury after re-
oxygenation may place statins as a potential prophylactic therapy 
in this clinical condition.
Methods
The experiments were performed in accordance to the 
Guide for the Care and Use of Laboratory Animals with approval 
of the Ethics Committee on Experimental Animal Research 
CEEA-IB-UNICAMP (protocol number: 1610-1).
Male Wistar rats (n = 30) weighing between 310 and 380 
g were used. Animals were allocated randomly into 3 groups: (i) 
Control group with no manipulation (Control; n = 12), (ii) 1-h OLV 
followed 1-h two-lung ventilation (OLV; n = 9) and (iii) 1-h OLV 
followed 1-h two-lung ventilation in rats previously treated with 
40 mg/kg of simvastatin (BioLab Farmacêutica Ltda, SP-Brazil) 
through oral gavage for 21 days before the surgical procedure 
(OLV + Simvastatin; n = 9). 
All animals were anesthetized with isoflurane 5%, 
tracheostomized and ventilated with pressure-controlled ventilator 
(Inter 3, Intermed®, SP, Brazil) with an inspired oxygen fraction 
(FiO2) of 60%, respiratory rate (RR) of 80 breaths per min, positive 
end expiratory pressure (PEEP) of 2 cmH2O and inspiratory 
pressure (IP) of 20 cmH2O, as previous described
11. The left 
femoral vein was dissected, and used for pancuronium bromide 
in bolus (1 mg/kg.h) administration. The same vein was used for 
administration of human albumin labeled with Iodine (125I) and 
for fluid replacement, keeping a 0.9% saline solution infusion (1 
mL/h). All animals were operated on a heated blanket with rectal 
temperature controlled between 36.0 to 37.5°C.
The left carotid artery was cannulated and maintained 
with 0.9% heparinized saline (5UI / mL) to obtain the blood 
arterial samples for gasometric analysis. The following gasometric 
parameters were evaluated: pH, PaO2, PaCO2, HCO3
-, BE and SO2.
A right parasternal thoracotomy with ipsilateral 
anterolateral extension was performed. To establish the OLV 
protocol, all animals underwent atraumatic right lung mobilization, 
with clamping of the right main bronchus, keeping bilateral 
pulmonary perfusion and left lung ventilation. During OLV, no 
modification on the previously established ventilator parameters 
was performed, and animals remained under the same ventilatory 
condition. The clamp was maintained during 60 min and a new 
blood sample for gasometric analysis at the final minute of the 
OLV was collected.
In both groups, immediately after clamp removal, lung 
recruitment maneuver was performed through a sustained inflation 
at 30 cmH2O during 30 sec
12, after which the ventilator parameters 
were adjusted to the previous values and remained unchanged 
during 60 min. At the end of this period, a third arterial sample 
for gases analysis was performed and, immediately thereafter, 
rats received 5% isoflurane concentration and were sacrificed by 
exsanguination.
Measurement of inflammatory markers in serum
A midline laparotomy to collect blood from the 
abdominal aorta was performed. The blood collected was 
processed and the serum was stored for posterior measurements of 
levels of C-reactive protein CRP (CRP) (Chemicon® International, 
CA, USA), TNF-α, IL-1β, IL-6 and IL-10 (R&D Systems®, MN, 
USA) using commercial kits, according to the manufacturer’s 
instructions.
Before removing the heart-lung block from the thoracic 
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cavity, the lungs of all animals were perfused with 40 mL of 0.9% 
saline solution from a height of 20 cm through cannulation of the 
pulmonary artery, followed by opening the left atrium for effluent 
drainage. After perfusion, the lungs were removed and subjected 
to analyze of inflammatory markers through quantification of 
the myeloperoxidase (MPO) activity and pulmonary protein 
extravasation (as detailed below).
Lung myeloperoxidase activity
The right and left lungs were removed and separately placed 
in a test tube in the presence of 0.5% hexadecyltrimethylammonium 
bromide in 50 mM potassium phosphate buffer (pH 6.0). The 
tissue samples were homogenized and centrifuged for 2 min at 
12.000 g, and the supernatant collected. MPO activity assay was 
performed using a microplate spectrophotometer (Spectra Max 
34; Molecular Devices, Sunnyvale, CA, USA). Briefly, the assay 
consisted of mixing a 5 μL sample with 200 μL of o-dianisidine 
solution (0.167 mg/mL o-dianisidine dihydrochoride; 0.0005% 
hydrogen peroxide) prior to reading the plate. The changes in 
absorbance were measured at 460 nm recorded at intervals of 15 
sec during 10 min. MPO activity was expressed as units of enzyme 
activity per milligram of tissue (UMPO)/mg. One unit of MPO 
was defined the enzyme amount that degrades one micromole of 
peroxide/min at 25ºC13.
Pulmonary protein extravasation 
Pulmonary protein extravasation was measured by 
means of intravenously injected 125I serum albumin (2.5 μCi/
kg) accumulation. The radioactivity present in blood samples 
and lung tissue was quantified separately for one minute each 
in a γ-counter14. The protein extravasation was expressed as the 
volume (in microlitres) of serum accumulated in the lung derived 
from the total count in 1 mL serum. 
Statistical analysis
Statistical analysis was performed using Software 
GraphPad Prism 5.00. All variables were tested for normal 
distribution. Parametric data were presented as means ± standard 
error of the mean (SEM), with p-values resulted of the comparison 
between groups by applying t-test or ANOVA followed by 
Bonferroni post-test. Differences were considered to be statistically 
significant for all procedures if p< 0.05.
Results
Activity of myeloperoxidase (MPO) in lung tissues
The MPO activity in the right and left lungs after 
OLV was significantly greater (24.5 ± 0.9 and 25.9 ± 1.0 µL/g, 
respectively) compared with animals under no manipulation (18.7 
± 6.0 and 17.2 ± 4.4 µL/g, respectively). Simvastatin treatment 
significantly reduced the MPO activity in the left lung after OLV 
(p = 0.044), without affecting the increased MPO in the right lungs 
(p = 0.3530; Figure 1). 
FIGURE 1 - Simvastatin (Simv) treatment prior to OLV reduced the 
myeloperoxidase (MPO) activity in the left lung tissue after one-lung 
ventilation (OLV) in rats. 
Measurement of MPO activity was performed in the 
right and left lungs of rats from the control, OLV and OLV+Simv 
groups. Results are shown as mean of % change ± SEM (n = 9), 
calculated based on the control group mean value. *p = 0.044 
(Student’s t test) compared to the left lung of OLV group.
Pulmonary microvascular permeability
The pulmonary protein extravasation in the right and left 
lungs after OLV (173.8 ± 27.7 and 121.5 ± 20.4 µL/g, respectively) 
differ significantly from animals under no manipulation (50.1 ± 
3.6 and 47.6 ± 3.8 µL/g, respectively). Prolonged treatment with 
simvastatin did not change significantly the pulmonary protein 
extravasation seen in the right and left lungs after OLV (222.9 ± 
19.3 and 176.9 ± 24.4 µL/g, respectively) (Figure 2).
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FIGURE 2 - Pulmonary protein extravasation. Data are represented 
as mean and SEM, with analysis performed by ANOVA followed by 
Bonferroni post-test (*p<0.05 versus right lung of Control group; # 
p<0.05 versus left lung of Control group).
Serum levels of IL-1β, TNF-α, IL-10, IL-6 and CRP
The IL-1β, TNF-α and IL-10 levels remained below the 
detection limit in all groups (62.5 pg/mL). The IL-6 and CRP levels 
were markedly higher in OLV group (p<0.05), but simvastatin 
treatment failed to affect the production of both mediators (Table 
1). 
TABLE 1 - Serum levels of IL-6 and CRP.
Control OLV OLV + Simvastatin
IL-6, ng/mL ND 4.0 ± 1.4* 5.1 ± 1.5*
CRP, mg/mL 0.68 ± 0.07 5.1 ± 0.3* 4.8 ± 0.4*
Data are presented as mean ± SEM from nine rats. * 
p<0.05 compared with Control Group (ANOVA followed by 
Bonferroni post test). OLV, one-lung ventilation. ND, not detected.
Gasometric parameters
Figure 2 shows the PaO2 in the experimental groups. 
During OLV, a significant decrease in PaO2, as observed in both 
non-treated and simvastatin-treated rats, was observed. PaO2 
values returned to baseline after lung re-expansion period and 
reestablishment of bilateral ventilation. No differences were 
observed between non-treated and simvastatin-treated rats (Figure 
3). 
FIGURE 3 - PaO2 values at the beginning of the protocol (initial), and 
after 1-h of OLV (bronchial occlusion) and subsequently to 1-h of two-
lung ventilation (final). Data represent mean ± SEM for nine rats. *p<0.05 
versus initial and final measurements in OLV group; #p<0.05 versus 
initial and final measurements in OLV+Simv group (ANOVA followed by 
Bonferroni post hoc test). OLV, one-lung ventilation. 
As shown in Table 2, no gasometric parameter (pH, 
PaCO2, HCO3
-, BE and SO2) showed significantly changes in 
an equal period when compared the groups that received or not 
simvastatin previous treatment. 
TABLE 2 - Blood gas analysis obtained in different 
stages of OLV followed by TLV.
OLV OLV + Simvastatin
pH Initial 7.41 ± 0.01 7.44 ± 0.01 
Occlusion 7.27 ± 0.04 7.29 ± 0.04 * 
Final 7.40 ± 0.01 7.35 ± 0.05 
PaCO2 (mmHg) Initial 38.98 ± 0.96 35.33 ± 1.81 
Occlusion 59.31 ± 8.79 56.63 ± 7.47 
Final 37.65 ± 1.17 48.93 ± 10.53 
HCO3- (mmol/L) Initial 24.76 ± 0.52 23.55 ± 0.79
Occlusion 24.99 ± 0.91 24.96 ± 0.47
Final 22.50 ± 0.50 23.71 ± 1.08
BE (mmol/L) Initial 0.62 ± 0.64 0.39 ± 0.59 
Occlusion
-2.67 ± 
0.69 *
-2.23 ± 0.92 
Final -1.46 ± 0.49 -1.844 ± 0.84 
SO2 (%) Initial 99.56 ± 0.06 99.59 ± 0.05 
Occlusion 95.41 ± 1.21 91.23 ± 2.28 *
Final 99.73 ± 0.02 99.39 ± 0.21 
Data are presented as mean ± SEM for nine rats. *p < 
0.05 versus initial (ANOVA followed by Bonferroni post hoc test). 
OLV, one-lung ventilation. 
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Discussion 
In the present study, we show that pre-operative treatment 
with simvastatin reduces remote pulmonary neutrophil infiltration, 
without affecting any other local or systemic parameter.
Neutrophils are the earliest cells recruited to tissues 
followed an inflammatory insult. These cells are an important 
source of reactive oxygen species, with clinical and experimental 
evidences indicating that these cells greatly contribute to the acute 
lung injury and acute respiratory distress syndrome4. Statins have 
been shown to have a potent anti-inflammatory effect in acute 
local inflammation, as a consequence of its inhibitory effect on 
polymorphonuclear leucocyte infiltration15. Accordingly, in our 
study, treatment with simvastatin significantly reduced the MPO 
activity in the left lung, which remained continuously ventilated 
throughout the experiment. Previous studies have shown that OLV 
can be consider a mechanism that increases lung microvascular 
permeability leading to edema formation in humans after lung 
resections16, with the same behavior reproduced in experimental 
studies using different animal species as well as diverse in the 
bronchial occlusion time10,17. However, no studies exist evaluating 
the effects of statins on the increased microvascular permeability 
in models lung re-expansion after bronchial occlusion. In the 
present study, OLV significantly increased the pulmonary vascular 
permeability after lung re-expansion; however, simvastatin pre-
treatment failed to affect the increased permeability. Simvastatin 
promotes a significant reduction in pulmonary vascular 
permeability in other models of pulmonary inflammation such as 
lung ischemia and reperfusion6. Whether these conflicting findings 
reflect differences in the dose of simvastatin used and experimental 
paradigm requires additional studies. 
Besides the local inflammatory response, its systemic 
repercussion was also investigated through analysis of serum 
inflammatory mediators. TNF-α, an early proinflammatory 
cytokine, activates other pro-inflammatory cytokines such as IL-
1β and IL-6. TNF-α and IL-1β activates the inflammatory cascade 
by producing many cytokines and chemokines and release of 
endothelial adhesion molecules18. In our study, the levels of the 
pro-inflammatory cytokines TNF-α, IL-1β and IL-10 remained 
below the limit of detection, which is suggestive that the 1-h 
period of OLV followed by an equal period of bilateral ventilation 
caused only a local pulmonary inflammatory response without 
systemic repercussion. This is consistent with a previous study in 
pigs undergoing a similar protocol17. We may also consider that 
volatile anesthetics reduces inflammatory responses in ischemia 
and reperfusion models due to inhibition of the TNF-α release19. 
The cytokine IL-6 was systemically detected, but no differences 
between untreated and simvastatin-treated groups were observed. 
Therefore, it is unlikely that reduction of pulmonary neutrophil 
infiltration by simvastatin reflects enhanced levels of IL-6. The 
IL-6 response to statin therapy has been controversial in the 
literature20. The CRP levels were largely greater in OLV group 
compared with control animals, but simvastatin failed to affect this 
increased production. 
Finally, regarding the gasometric analysis, pH and 
SO2 values decreased significantly at the end of the OLV period 
compared with baseline measurements in the simvastatin group. 
A similar response was verified in BE data measured in the 
untreated group. Considering that no intervention was performed 
to control the respiratory acidosis that followed the occlusion 
period, the kidney function was not sufficient to compensate for 
the homeostase during the OLV. However, in all cases a regression 
to the baseline parameters was observed after a relatively short 
period of bilateral ventilation (1 hour). As seen for the first time, 
simvastatin treatment caused no protective effect in any evaluated 
gasometric parameter during OLV. A previous study in rats 
undergoing cardiopulmonary bypass showed a large protective 
effect by simvastatin on the decreased PaO2 values which was 
attributed to increased nitric oxide production after hypoxia8. 
However, it is worth mentioning that in the present model no 
severe hypoxic condition occurred, even during OLV.
Conclusions 
In an experimental one-lung ventilation model pre-
operative treatment with simvastatin reduces remote neutrophil 
infiltration in the ventilated lung. Our findings suggest that 
simvastatin may be of therapeutic value in OLV-induced pulmonary 
inflammation deserving clinical investigations.
References 
1.  Olivant Fisher A, Husain K, Wolfson MR, Hubert TL, Rodriguez 
E, Shaffer TH, Shaffer TH, Theroux MC. Hyperoxia during one 
lung ventilation: inflammatory and oxidative responses. Pediatr 
Pulmonol. 2012;47(10):979-86.
2.  Tsai JA, Lund M, Lundell L, Nilsson-Ekdahl K. One-lung ventilation 
during thoracoabdominal esophagectomy elicits complement 
activation. J Surg Res. 2009;152(2):331-7.
3.  Gothard J. Lung injury after thoracic surgery and one-lung 
ventilation. Curr Opin Anaesthesiol. 2006;19(1):5-10. 
4.  Ware LB, Matthay MA. The acute respiratory distress syndrome. N 
Engl J Med. 2000;342(18):1334-49. 
5.  Hothersall E, McSharry C, Thomson NC. Potential therapeutic role 
for statins in respiratory disease. Thorax. 2006;61(8):729-34.
6.  Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga C, Mulligan 
Leite CF et al.
250 - Acta Cirúrgica Brasileira - Vol. 28 (4) 2013
MS. Simvastatin ameliorates injury in an experimental model of lung 
ischemia-reperfusion. J Thorac Cardiovasc Surg. 2003;126(2):482-
9. 
7.  Pruefer D, Scalia R, Lefer AM. Simvastatin inhibits leukocyte-
endothelial cell interactions and protects against inflammatory 
processes in normocholesterolemic rats. Arterioscler Thromb Vasc 
Biol. 1999;19(12):2894-900. 
8.  Shao H, Shen Y, Liu H, Dong G, Qiang J, Jing H. Simvastatin 
suppresses lung inflammatory response in a rat cardiopulmonary 
bypass model. Ann Thorac Surg. 2007;84(6):2011-8. 
9.  Johnson BA, Iacono AT, Zeevi A, McCurry KR, Duncan SR. Statin 
use is associated with improved function and survival of lung 
allografts. Am J Respir Crit Care Med. 2003;167(9):1271-8. 
10.  Leite CF, Calixto MC, Toro IFC, Antunes E, Mussi RK. 
Characterization of Pulmonary and systemic inflammatory 
responses produced by lung re-expansion after one-lung ventilation. 
J Cardiothorac Vasc Anesth. 2012;26(3):427-32. 
11.  Leite CF, Toro IFC, Antunes E, Mussi RK. Standardization of a 
method of prolonged thoracic surgery and mechanical ventilation 
in rats to evaluate local and systemic inflammation. Acta Cir Bras. 
2011;26(1):38-43. 
12.  de Carvalho MEP, Dolhnikoff M, Meireles SI, Reis LFL, Martins 
MA, Deheinzelin D. Effects of overinflation on procollagen 
type III expression in experimental acute lung injury. Crit Care. 
2007;11(1):R23. 
13.  Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement 
of cutaneous inflammation: estimation of neutrophil content with an 
enzyme marker. J Invest Dermatol. 1982;78(3):206-9. 
14.  Bhabra MS, Hopkinson DN, Shaw TE, Onwu N, Hooper TL. 
Controlled reperfusion protects lung grafts during a transient early 
increase in permeability. Ann Thorac Surg. 1998;65(1):187-92. 
15.  Nezić L, Skrbić R, Dobrić S, Stojiljković MP, Jaćević V, Satara 
SS, Milovanović ZA, Stojaković N. Simvastatin and indomethacin 
have similar anti-inflammatory activity in a rat model of acute local 
inflammation. Basic Clin Pharmacol Toxicol. 2009;104(3):185-91.
16.  Padley SPG, Jordan SJ, Goldstraw P, Wells AU, Hansell DM. 
Asymmetric ARDS following pulmonary resection: CT findings 
initial observations. Radiology. 2002;223(2):468-73. 
17.  Yin K, Gribbin E, Emanuel S, Orndorff R, Walker J, Weese J, 
Fallahnejad M. Histochemical alterations in one lung ventilation. J 
Surg Res. 2007;137(1):16-20. 
18.  Liu D, Zeng BX, Zhang SH, Yao SL. Rosiglitazone, an agonist 
of peroxisome proliferator-activated receptor gamma, reduces 
pulmonary inflammatory response in a rat model of endotoxemia. 
Inflamm Res. 2005;54(11):464-70. 
19.  Liu R, Ishibe Y, Ph D, Ueda M. Isoflurane-sevoflurane adminstration 
before ischemia attenuates ischemia-reperfusion-induced injury in 
isolated rat lungs. Anesthesiology. 2000;92(3):833-40. 
20.  Pleiner J, Schaller G, Mittermayer F, Zorn S, Marsik C, Polterauer S, 
Kapiotis S, Wolzt M. Simvastatin prevents vascular hyporeactivity 
during inflammation. Circulation. 2004;110(21):3349-54.  
Correspondence:
Ricardo Kalaf Mussi
Departamento de Cirurgia – Faculdade de Ciências Médicas
UNICAMP
Rua Tessália Vieira de Camargo, 126
13083-887  Campinas - SP  Brasil
Tel.: (55 19)3521-9441
Fax: (55 19)3521-8043
rkm@unicamp.br
Received: December 18, 2012
Review: February 20, 2013
Accepted: March 19, 2013
Conflic of interest: none
Financial sources: Coordination of Improvement for Higher Academic 
Staff (CAPES) and Sao Paulo Research Foundation (FAPESP)
1Research performed at Laboratory of Inflammation, Department of 
Pharmacology, Faculty of Medical Sciences, State University of Campinas 
(UNICAMP), Brazil. Part of Master degree thesis, Postgraduate Program 
in Surgical Sciences, UNICAMP. Tutor: Prof. Ricardo Kalaf Mussi.
